Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro
Autoři:
Maria Ribeiro Santos Morard aff001; Ricardo Betanho Martins aff001; Ana Carolina Lopes Ribeiro aff002; Pedro Guimarães Rocha Lima aff001; Beatriz dos Santos Carvalho aff003; José Carlos Baldelim Santiago Junior aff003
Působiště autorů:
UNIRIO—Universidade Federal do Estado do Rio De Janeiro, Rio de Janeiro, RJ, Brazil
aff001; UNESA—Universidade Estácio de Sá, Rio de Janeiro, RJ, Brazil
aff002; FMP–Faculdade de Medicina de Petrópolis, Petrópolis, RJ, Brazil
aff003
Vyšlo v časopise:
PLoS ONE 14(9)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0220664
Souhrn
Background
Hyperhidrosis is a pathological condition defined by excessive sweating beyond thermoregulatory physiological needs, which can cause substantial psychological impact and impairment of daily activities. Studies regarding its prevalence, however, are scarce and vary widely in their findings. The population of medical students is a particularly interesting subset for its recurring demand of physical contact during patient examination or procedures, and the potential for professional adversity. We aimed at furthering the comprehension of this disease prevalence and characteristics among medical students.
Methods
Questionnaires inquiring about the presence and characteristics of Primary Hyperhidrosis (PH) were applied through either written or digital means to all eligible medical students enrolled in three Medical Schools in the State of Rio de Janeiro who agreed to take part in the study. Demographic data regarding gender, ethnicity, current age, weight and height was collected in addition to clinical data (sweat site, age of onset, familial history, severity and previous treatments). Severity was evaluated through the Hyperhidrosis Disease Severity Scale (HDSS) and a symptoms survey.
Findings
Our response rate was roughly 1/3 of all eligible students (900/2700). PH prevalence was 20.56% (185/900). It was similar between men and women (23.08% and 19.41%, respectively) and strongly associated with family history of the disease (Prevalence Ratio of 4.27). Regarding ethnicity, of the total sample 73.78% (664/900) self-declared white, among which 19.28% (128/664) had PH. Mixed-race and other ethnicities encompassed 26.22% (236/900) of the sample, among which 24.15% (57/236) had PH. Most positive subjects (64.32%) presented associated forms of PH. Overall involvement of each site (both associated and isolated) was: 63.78% axillary, 50.81% palmar, 43.24% plantar, 20.54% craniofacial, 18.38% facial flushing and 2.16% gustatory sweating. Mean current age was 23.11(±4.04) years for PH patients, and age of onset was ≤18 years in 93.94% of cases. Regarding body mass index (BMI), 71.09% of PH patients had BMI<25kg/m2 and only 4.69% presented BMI≥30kg/m2, none ≥35kg/m2. Some degree of life quality impairment was reported by 89.20% of PH patients, and 23.89% had HDSS 3 or 4 (moderate to severe).
Conclusions
PH prevalence among Rio de Janeiro medical students was 20.56%, similar between men and women, predominating associated presentations, axillary, palmar and plantar sites, strong familial history, age of onset before 18 years, and some degree of life impairment.
Klíčová slova:
Biology and life sciences – Research and analysis methods – People and places – Geographical locations – Anatomy – Integumentary system – Skin – Medicine and health sciences – Physiology – Research design – Body fluids – Head – Survey research – Face – Surgical and invasive medical procedures – South America – Brazil – Questionnaires – Epidemiology – Exocrine glands – Sweat glands – Sweat – Ethnic epidemiology
Zdroje
1. Schick CH. Pathophysiology of Hyperhidrosis. Thorac Surg Clin. 2016;26(4):389–93. doi: 10.1016/j.thorsurg.2016.06.002 27692196
2. Menzinger S, Quenan S. [Evaluation and management of hyperhidrosis]. Rev Med Suisse. 2017;13(556):710–4. 28722382
3. Moraites E, Vaughn OA, Hill S. Incidence and prevalence of hyperhidrosis. Dermatol Clin. 2014;32(4):457–65. doi: 10.1016/j.det.2014.06.006 25152338
4. Maillard H, Lecouflet M. [Management of hyperhidrosis]. Ann Dermatol Venereol. 2015;142(4):252–61. doi: 10.1016/j.annder.2014.11.005 25697587
5. Muthusamy A, Gajendran R, Ponnan S, Thangavel D, Rangan V. A Study on the Impact of Hyperhidrosis on the Quality of Life among College Students. J Clin Diagn Res. 2016;10(6):Cc08–10. doi: 10.7860/JCDR/2016/19495.8061 27504282
6. Stefaniak T, Tomaszewski KA, Proczko-Markuszewska M, Idestal A, Royton A, Abi-Khalil C. Is subjective hyperhidrosis assessment sufficient enough? prevalence of hyperhidrosis among young Polish adults. J Dermatol. 2013;40(10):819–23. doi: 10.1111/1346-8138.12238 23915355
7. Augustin M, Radtke MA, Herberger K, Kornek T, Heigel H, Schaefer I. Prevalence and disease burden of hyperhidrosis in the adult population. Dermatology. 2013;227(1):10–3. doi: 10.1159/000351292 23988406
8. Lima SO, Aragao JF, Machado Neto J, Almeida KB, Menezes LM, Santana VR. Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil. An Bras Dermatol. 2015;90(5):661–5. doi: 10.1590/abd1806-4841.20153859 26560211
9. Liu Y, Bahar R, Kalia S, Huang RY, Phillips A, Su M, et al. Hyperhidrosis Prevalence and Demographical Characteristics in Dermatology Outpatients in Shanghai and Vancouver. PLoS One. 2016;11(4):e0153719. doi: 10.1371/journal.pone.0153719 27105064
10. Fujimoto T, Kawahara K, Yokozeki H. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis. J Dermatol. 2013;40(11):886–90. doi: 10.1111/1346-8138.12258 24106874
11. Fenili R, Demarchi AR, Fistarol ED, Matiello M, Delorenze LM. [Prevalence of hyperhidrosis in the adult population of Blumenau-SC, Brazil]. An Bras Dermatol. 2009;84(4):361–6. doi: 10.1590/s0365-05962009000400007 19851668
12. Shayesteh A, Janlert U, Brulin C, Boman J, Nylander E. Prevalence and Characteristics of Hyperhidrosis in Sweden: A Cross-Sectional Study in the General Population. Dermatology. 2016;232(5):586–91. doi: 10.1159/000448032 27576462
13. Westphal FL, de Carvalho MA, Lima LC, de Carvalho BC, Padilla R, Araujo KK. Prevalence of hyperhidrosis among medical students. Rev Col Bras Cir. 2011;38(6):392–7. 22267136
14. Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308(10):743–9. doi: 10.1007/s00403-016-1697-9 27744497
15. Tu YR, Li X, Lin M, Lai FC, Li YP, Chen JF, et al. Epidemiological survey of primary palmar hyperhidrosis in adolescent in Fuzhou of People's Republic of China. Eur J Cardiothorac Surg. 2007;31(4):737–9. doi: 10.1016/j.ejcts.2007.01.020 17314049
16. Li X, Chen R, Tu YR, Lin M, Lai FC, Li YP, et al. Epidemiological survey of primary palmar hyperhidrosis in adolescents. Chin Med J (Engl). 2007;120(24):2215–7.
17. Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51(2):241–8. doi: 10.1016/j.jaad.2003.12.040 15280843
18. Lai FC, Tu YR, Li YP, Li X, Lin M, Chen JF, et al. Nation wide epidemiological survey of primary palmar hyperhidrosis in the People's Republic of China. Clin Auton Res. 2015;25(2):105–8. doi: 10.1007/s10286-014-0259-5 25381140
19. Hasimoto EN, Cataneo DC, Reis TAD, Cataneo AJM. Hyperhidrosis: prevalence and impact on quality of life. J Bras Pneumol. 2018;44(4):292–8. doi: 10.1590/S1806-37562017000000379 30066741
20. Silva SLDS, Fiorelli RKA, Morard MRS. Evaluation of the quality of life of patients with primary hyperhidrosis submitted to videothoracoscopic sympathectomy. Rev Col Bras Cir. 2017;44(4):323–7. doi: 10.1590/0100-69912017004005 29019534
21. Lima SO, de Santana VR, Valido DP, de Andrade RLB, Fontes LM, Leite VHO, et al. Retroperitoneoscopic lumbar sympathectomy for plantar hyperhidrosis. J Vasc Surg. 2017;66(6):1806–13. doi: 10.1016/j.jvs.2017.05.126 29169540
22. Ak M, Dincer D, Haciomeroglu B, Akarsu S, Lapsekili N, Ada S. The evaluation of primary idiopathic focal hyperhidrosis patients in terms of alexithymia. J Health Psychol. 2013;18(5):704–10. doi: 10.1177/1359105312454908 22933577
23. Ak M, Dincer D, Haciomeroglu B, Akarsu S, Cinar A, Lapsekili N. Temperament and character properties of primary focal hyperhidrosis patients. Health Qual Life Outcomes. 2013;11:5. doi: 10.1186/1477-7525-11-5 23311945
24. Bahar R, Zhou P, Liu Y, Huang Y, Phillips A, Lee TK, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75(6):1126–33. doi: 10.1016/j.jaad.2016.07.001 27567033
25. Sanclemente G, Burgos C, Nova J, Hernandez F, Gonzalez C, Reyes MI, et al. The impact of skin diseases on quality of life: A multicenter study. Actas Dermosifiliogr. 2017;108(3):244–52. doi: 10.1016/j.ad.2016.11.008 28063525
26. Varella AY, Fukuda JM, Teivelis MP, Campos JR, Kauffman P, Cucato GG, et al. Translation and validation of Hyperhidrosis Disease Severity Scale. Rev Assoc Med Bras (1992). 2016;62(9):843–7.
27. Hashmonai M, Cameron AEP, Connery CP, Perin N, Licht PB. The Etiology of Primary Hyperhidrosis: A Systematic Review. Clin Auton Res. 2017;27(6):379–83. doi: 10.1007/s10286-017-0456-0 28823102
Článok vyšiel v časopise
PLOS One
2019 Číslo 9
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Úspěšná resuscitativní thorakotomie v přednemocniční neodkladné péči
- Fixní kombinace paracetamol/kodein nabízí synergické analgetické účinky
Najčítanejšie v tomto čísle
- Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats
- CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
- Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
- Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania